secwatch.observer — SEC 8-K summary
======================================

Issuer:     Talis Biomedical Corp (—)
CIK:        0001584751
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0000950170-23-001171
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Talis Biomedical receives 180-day extension to meet Nasdaq $1 bid price rule; deadline July 24, 2023
--------------------------------------------------------------------------------

- Transferred stock listing from Nasdaq Global Market to Capital Market on Jan 24, 2023.
- Received additional 180-day grace period, until July 24, 2023, to meet $1.00 minimum bid price.
- Must have closing bid price at least $1.00 for 10 consecutive business days to regain compliance.
- Intends to cure deficiency by effecting a reverse stock split if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1584751/000095017023001171/0000950170-23-001171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1584751/000095017023001171/tlis-20230124.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer